483 Response AMRI Rensselaer Jan 2013

Dana Razzano FDA, William Rennells FDA$119.00 - Available Now

FDA investigators audited the AMRI Rensselaer - Rensselaer, NY, United States facility and issued inspectional observation (via FDA 483) on 30 Jan 2013.

Product details

  • Category:
  • Inspection end: 30 Jan 2013
  • Location: Rensselaer, United States
  • FEI: 1310298
Add To Cart